Literature DB >> 6725833

A comparison of the Snellen chart and the S-chart for visual acuity assessment in amblyopia.

B Wick, C M Schor.   

Abstract

A standard Snellen chart and a chart that controls contour interaction effects and gives equal numbers of acuity trials for all letter sizes (the S-chart) were used to compare visual acuities for 30 amblyopic patients (17 with central fixation, 13 with eccentric fixation). No statistically significant difference appeared between S-chart and Snellen acuity in the acuity range 20/30 to 20/80. When amblyopic acuity was below 20/100, S-chart and Snellen acuities differed significantly.

Entities:  

Mesh:

Year:  1984        PMID: 6725833

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  5 in total

1.  The development of a "reduced logMAR" visual acuity chart for use in routine clinical practice.

Authors:  D A Rosser; D A Laidlaw; I E Murdoch
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Surgical treatment for severe visual compromised patients after pituitary apoplexy.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Kuo-Chen Wei; Cheng-Chih Liao; Peng-Wei Hsu; Ying-Cheng Huang; Yao-Liang Chen; Li-Ju Lai; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

3.  Reliability of the Snellen chart.

Authors:  P McGraw; B Winn; D Whitaker
Journal:  BMJ       Date:  1995-06-10

4.  A double dissociation of the acuity and crowding limits to letter identification, and the promise of improved visual screening.

Authors:  Shuang Song; Dennis M Levi; Denis G Pelli
Journal:  J Vis       Date:  2014-05-05       Impact factor: 2.240

5.  Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.

Authors:  Iryna A Falkenstein; Denine E Cochran; Stanley P Azen; Laurie Dustin; Ajay M Tammewar; Igor Kozak; William R Freeman
Journal:  Ophthalmology       Date:  2007-08-13       Impact factor: 12.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.